Asp Isotopes Inc. (ASPI) intrinsic value & 10-year financials
Asp Isotopes Inc. (ASPI) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 5 fiscal years revenue grew 642.1% a year to $23.8M, with an average return on invested capital of -189.5%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $2.14
- Market cap
- $177.6M
- Revenue (FY2025)
- $23.8M
- Revenue growth (5-yr CAGR)
- 642.1%
- ROIC (10-yr avg)
- -189.5%
- Free cash flow (FY2025)
- -$47.4M
ASPI 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $23.8M | -$159.8M | -$2.11 | -$47.4M | -251.2% | 135.8% |
| FY2024 | $4.1M | -$32.4M | -$0.63 | -$26.4M | -635.9% | -687.5% |
| FY2023 | $433.0K | -$16.3M | -$0.49 | -$7.7M | -3704.6% | -122.2% |
| FY2022 | $0 | -$4.9M | — | -$7.4M | — | -84.0% |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
ASP Isotopes Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
ASP Isotopes Inc. has historically struggled to out-earn its cost of capital, averaging just -19.3% ROIC.
ASP Isotopes Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, ASP Isotopes Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-70.09 per share.